Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Renal Fibrosis

International Journal of Molecular Sciences

卷:21

Kwan-Kyu Park¹  Hyun-Ju Kim¹  HyunJin Jung² 

[1] Department of Pathology, College of Medicine, Catholic University of Daegu, Gyeongsan 42472, Korea;

[2] Department of Urology, College of Medicine, Catholic University of Daegu, Gyeongsan 42472, Korea;

关键词: long noncoding RNA;    renal fibrosis;    therapeutic target;   

DOI  :  10.3390/ijms21082698

来源: DOAJ

【 摘 要 】

Many studies have made clear that most of the genome is transcribed into noncoding RNAs, including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), both of which can affect different cell features. LncRNAs are long heterogeneous RNAs that regulate gene expression and a variety of signaling pathways involved in cellular homeostasis and development. Several studies have demonstrated that lncRNA is an important class of regulatory molecule that can be targeted to change cellular physiology and function. The expression or dysfunction of lncRNAs is closely related to various hereditary, autoimmune, and metabolic diseases, and tumors. Specifically, recent work has shown that lncRNAs have an important role in kidney pathogenesis. The effective roles of lncRNAs have been recognized in renal ischemia, injury, inflammation, fibrosis, glomerular diseases, renal transplantation, and renal-cell carcinoma. The present review focuses on the emerging role and function of lncRNAs in the pathogenesis of kidney inflammation and fibrosis as novel essential regulators. Although lncRNAs are important players in the initiation and progression of many pathological processes, their role in renal fibrosis remains unclear. This review summarizes the current understanding of lncRNAs in the pathogenesis of kidney fibrosis and elucidates the potential role of these novel regulatory molecules as therapeutic targets for the clinical treatment of kidney inflammation and fibrosis.

【 授权许可】

Unknown